Head and Neck Cancer - Featured Clinical Trials
The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:
- Treatment for Recurrent Head and Neck Cancer
(Posted: 01/31/2006, Updated: 01/08/2007) - In this clinical trial, researchers seek to determine if giving concurrent radiation therapy and chemotherapy to patients with inoperable, recurrent head and neck cancer who were treated initially with radiation therapy will improve survival rates for these patients.
- Studying Dyskeratosis Congenita
(Posted: 07/11/2006) - Persons with a rare disorder called dyskeratosis congenita (DC) tend to have a high risk of developing bone marrow failure, leukemia, or certain carcinomas. NCI is undertaking an intensive assessment of families with DC to learn more about how genes associated with it lead to cancer development and to identify new susceptibility genes for DC.
- Treatment for Locally Advanced Head and Neck Cancer
(Posted: 07/05/2006) - This trial will enroll patients with locally advanced squamous cell carcinoma of the larynx, oropharynx, or hypopharynx. All patients will be treated with radiotherapy and cisplatin. In addition, half of the patients will be treated with a monoclonal antibody called cetuximab.
- Study of Cancer Susceptibility Among Patients with Inherited Bone Marrow Failure Syndromes
(Posted: 06/29/2004) - Persons with inherited bone marrow failure syndromes (IBMFS) tend to have a very high risk of developing certain cancers. Researchers are assembling a study population that includes IBMFS patients and their family members.